What is an SMI soft mist inhaler?

An SMI (Soft Mist Inhaler) delivers medication as a slow-moving, fine soft mist with high lung deposition, making inhalation easier for patients than conventional inhalers.

How does an SMI inhaler differ from a traditional nebulizer?

A soft mist inhaler produces a stable, pre-set aerosol dose in a compact handheld device, while traditional jet or ultrasonic nebulizers need a larger machine and longer treatment time.

Is the DSB soft mist inhaler FDA and CE certified?

Yes. DSB Medical manufactures soft mist inhalers under FDA, CE MDR and ISO 13485 certified quality systems, with OEM/ODM available for drug delivery programs.

Can DSB provide OEM/ODM for SMI inhalers?

Yes. DSB Medical offers OEM/ODM, private labeling and device customization for soft mist inhalers and related drug delivery devices.

About Careers Investors

Language
- 中文简体
- English
- Español
- 日本語
- عرب .

Home

Soft Mist Inhaler (SMI)

Category: Featured recommend Products

Consult Back

Product Details

Product image	Market prospects
	´ Compressed liquid Medicinal soft-mist nebulization device, Mechanical atomization, free of propellants. 。 ◎ In Asthma/COPD In the overall branded pharmaceutical market, LAMA/LABA Class of drugs from 2015 Year to 2020 In [year], this will be the category of drugs with the most pronounced market growth. OLD and LABA When used in combination, it can significantly improve pulmonary function compared with monotherapy, and with… LABA/ICS The dominant force in the class of drugs Advair 、 COPD the gold standard Spiriva In contrast, although these drugs take longer to take effect, LAMA/LABA Class of drugs in blocking M While acting as a receptor, it can also be simultaneously activated. beta Receptors, whose potent synergistic effects make such drugs promising to become COPD First-line medication. This of the field The medications are: Ultibro 、 Anoro 、 Duaklir 、 Bevespi 、 Stiolto ◎ Global The first one LAMA/LABA Class of drugs is Ultibro ，2013 It was first listed in Europe this year. 2015 Year, Ultibro The sales revenue is 2.6 billion dollars ; Anoro at 2014 It entered the U.S. market that year, becoming the world’s first to do so. LAMA/LABA Drug-like. 2015 Annual sales revenue is 1.2 billion dollars 。

Product image

Market prospects

´ Compressed liquid Medicinal soft-mist nebulization device, Mechanical atomization, free of propellants. 。

◎ In Asthma/COPD In the overall branded pharmaceutical market, LAMA/LABA Class of drugs from 2015 Year to 2020 In [year], this will be the category of drugs with the most pronounced market growth. OLD and LABA When used in combination, it can significantly improve pulmonary function compared with monotherapy, and with… LABA/ICS The dominant force in the class of drugs Advair 、 COPD the gold standard Spiriva In contrast, although these drugs take longer to take effect, LAMA/LABA Class of drugs in blocking M While acting as a receptor, it can also be simultaneously activated. beta Receptors, whose potent synergistic effects make such drugs promising to become COPD First-line medication. This of the field The medications are: Ultibro 、 Anoro 、 Duaklir 、 Bevespi 、 Stiolto

◎ Global The first one LAMA/LABA Class of drugs is Ultibro ，2013 It was first listed in Europe this year. 2015 Year, Ultibro The sales revenue is 2.6 billion dollars ; Anoro at 2014 It entered the U.S. market that year, becoming the world’s first to do so. LAMA/LABA Drug-like. 2015 Annual sales revenue is 1.2 billion dollars 。

Product Specifications

Item	Specification
Product type	Soft Mist Inhaler (SMI) unit
Actuation	Mechanical atomization, propellant-free
Aerosol delivery	Slow, long-duration soft mist for high lung deposition
Application	Liquid inhalation drug formulations
Materials	Medical-grade device materials; full material specification available on request
Compliance	CE MDR, ISO 13485 and FDA-registered manufacturing quality system
OEM/ODM	Available, including device customization and private labeling

Frequently Asked Questions

Question	Answer
What is a soft mist inhaler?	A soft mist inhaler (SMI) is a handheld inhalation device that releases a slow, long-duration aerosol cloud, allowing more time for the patient to inhale and improving drug deposition in the lungs.
Does the DSB SMI use propellants?	No. The DSB SMI uses mechanical atomization and is propellant-free.
Which patients benefit from an SMI?	SMI devices are especially useful for asthma, COPD and other respiratory drug-delivery programs where coordination between actuation and inhalation is challenging.
Can DSB customize the device?	Yes. DSB Medical provides OEM/ODM, device customization and private labeling for soft mist inhaler programs.
What certifications support the SMI program?	DSB Medical is a CE MDR, ISO 13485 and FDA-registered drug delivery device manufacturer.

Keywords: Soft Mist Inhaler (SMI)

Powder Inhaler (DPI)

COOKIES

Our website uses cookies and similar technologies to personalize the advertising shown to you and to help you get the best experience on our website. For more information, see our Privacy & Cookie Policy

COOKIES

required

These cookies are necessary for basic functions such as payment. Standard cookies cannot be turned off and do not store any of your information.

analyze

These cookies collect information, such as how many people are using our site or which pages are popular, to help us improve the customer experience. Turning these cookies off will mean we can't collect information to improve your experience.

Feature

These cookies enable the website to provide enhanced functionality and personalization. They may be set by us or by third-party providers whose services we have added to our pages. If you do not allow these cookies, some or all of these services may not function properly.

advertise

These cookies help us understand what you are interested in so that we can show you relevant advertising on other websites. Turning these cookies off will mean we are unable to show you any personalized advertising.